title: Vasculitides and the Complement System: a Comprehensive Review.
abstract: Systemic vasculitides are a group of rare diseases characterized by inflammation of the arterial or venous vessel wall, causing stenosis or thrombosis. Clinical symptoms may be limited to skin or to other organs or may include multiple manifestations as systemic conditions. The pathogenesis is related to the presence of leukocytes in the vessels and to the IC deposition, which implies the activation of the complement system (CS) and then the swelling and damage of vessel mural structures. The complement system (CS) is involved in the pathogenesis of several autoimmune diseases, including systemic vasculitides. This enzymatic system is a part of the innate immune system, and its function is linked to the modulation of the adaptive immunity and in bridging innate and adaptive responses. Its activation is also critical for the development of natural antibodies and T cell response and for the regulation of autoreactive B cells. Complement triggering contributes to inflammation-driven tissue injury, which occurs during the ischemia/reperfusion processes, vasculitides, nephritis, arthritis, and many others diseases. In systemic vasculitides, a group of uncommon diseases characterized by blood vessel inflammation, the contribution of CS in the development of inflammatory damage has been demonstrated. Treatment is mainly based on clinical manifestations and severity of organ involvement. Evidences on the efficacy of traditional immunosuppressive therapies have been collected as well as data from clinical trials that involve the modulation of the CS. In particular in small-medium-vessel vasculitides, the CS represents an attractive target. Herein, we reviewed the pathogenetic role of CS in these systemic vasculitides as urticarial vasculitis, ANCA-associated vasculitides, anti-glomerular basement membrane disease, cryoglobulinaemic vasculitides, Henoch-Schönlein purpura/IgA nephropathy, and Kawasaki disease and therefore its potential therapeutic use in this context.
authors.affiliation: Rheumatology Allergology and Clinical Immunology Department of "Medicina dei Sistemi", University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy. maria.sole.chimenti@uniroma2.it.
authors.forename: Maria Sole
authors.initials: MS
authors.lastname: Chimenti
authors.affiliation: Rheumatology Allergology and Clinical Immunology Department of "Medicina dei Sistemi", University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.
authors.forename: Eleonora
authors.initials: E
authors.lastname: Ballanti
authors.affiliation: Rheumatology Allergology and Clinical Immunology Department of "Medicina dei Sistemi", University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Triggianese
authors.affiliation: Rheumatology Allergology and Clinical Immunology Department of "Medicina dei Sistemi", University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Perricone
mesh_terms: D000818:Animals; D000974:Antibodies, Antinuclear / Q000378:metabolism; D000936:Antigen-Antibody Complex / Q000378:metabolism*; D015551:Autoimmunity; D001402:B-Lymphocytes / Q000276:immunology*; D001808:Blood Vessels / Q000378:metabolism* / Q000473:pathology; D003165:Complement System Proteins / Q000378:metabolism*; D003251:Constriction, Pathologic; D006801:Humans; D007167:Immunotherapy; D007249:Inflammation; D056647:Systemic Vasculitis / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*; D013927:Thrombosis
chemical_list: D000974:Antibodies, Antinuclear; D000936:Antigen-Antibody Complex; D003165:Complement System Proteins
keywords: ANCA; Anti-complement therapy; Complement system; Cryoglobulinemia; Urticarial vasculitis; Vasculitides